Financhill
Back

Novo Nordisk AS Vs. Genmab AS Industry Stock Comparison

Sell
34

NONOF
Novo Nordisk AS

Last Price:
103.75
Seasonality Move:
10.92%
Sell
25

GMAB
Genmab AS

Last Price:
20.47
Seasonality Move:
3.28%
Sell
34
Novo Nordisk AS (NONOF) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NONOF] share price is $105.49. The Score for NONOF is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • NONOF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Genmab AS (GMAB) is a Sell

Is Genmab AS a Buy, Sell or Hold?

  • The current Genmab AS [GMAB] share price is $20.45. The Score for GMAB is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • GMAB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NONOF Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $105.49
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing buying pressure, which is a positive indicator for future bullish movement.

GMAB Stock Price Chart

What is Genmab AS's stock price today?

  • The Genmab AS share price today is $20.45
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GMAB is experiencing slight selling pressure.

NONOF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.96 Sell
Relative Strength Index (14 RSI): 42.96 Sell
Chaikin Money Flow: 32377 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (104.78 - 115) Sell
Bollinger Bands (100): (113.85 - 136.93) Sell

GMAB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.79 Sell
Relative Strength Index (14 RSI): 25.28 Sell
Chaikin Money Flow: -57518 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.45 - 23.25) Sell
Bollinger Bands (100): (23.03 - 27.51) Sell

NONOF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 104.24 Buy
20-day SMA: 108.18 Sell
50-day SMA: 116.71 Sell
200-day SMA: 127.84 Sell
8-day EMA: 104.48 Buy
20-day EMA: 107.97 Sell
50-day EMA: 115.05 Sell
200-day EMA: 120.69 Sell

GMAB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.34 Sell
20-day SMA: 22.22 Sell
50-day SMA: 23.4 Sell
200-day SMA: 26.95 Sell
8-day EMA: 21.16 Sell
20-day EMA: 22 Sell
50-day EMA: 23.31 Sell
200-day EMA: 26.81 Sell

Novo Nordisk AS Earnings Growth & NONOF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.

Genmab AS Earnings Growth & GMAB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.16 per share, and an increase next year of $0.28 per share.

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Genmab AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):